Skip to main content
Screener/Healthcare/Biotechnology

KPTI — Karyopharm Therapeutics Inc.

NASDAQ
$0.63-0.25 (-28.81%)
Penny StockUnder $1Under $5Healthcare
$0.31
$10.99
$0.58
$0.90
EPS (TTM)$-15.07
P/E Ratio-0.79
Dividend Yield—
Market Cap$10.9M
Volume3.05M
Prev Close$0.88
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$35.1M-$22.4M$-1.2496.1%-63.9%
Q4 '25$34.1M-$102.2M$-5.6995.6%-299.9%
Q3 '25$44.0M-$33.1M$-3.8295.2%-75.2%
Q2 '25$37.9M-$37.3M$-4.3297.2%-98.2%
Q1 '25$30.0M-$23.5M$-2.7795.7%-78.2%
Q4 '24$30.5M-$30.8M$-3.6795.6%-100.8%
Q3 '24$38.8M-$32.1M$-3.8596.6%-82.7%
Q2 '24$42.8M$23.8M$-2.9796.4%55.6%
Get Your Daily Market Recap